Diphtheria epidemiology and demographics

Jump to navigation Jump to search

Diphtheria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Diphtheria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Electrocardiogram

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diphtheria epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diphtheria epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diphtheria epidemiology and demographics

CDC on Diphtheria epidemiology and demographics

Diphtheria epidemiology and demographics in the news

Blogs on Diphtheria epidemiology and demographics

Directions to Hospitals Treating Diphtheria

Risk calculators and risk factors for Diphtheria epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.

Overview

Diphtheria is found worldwide but is rare in the United States. Diphtheria causes significant illness and death in developing countries where vaccination coverage is low.

Epidemiology and Demographics

Incidence

  • Diptheria is very rare; the incidence in 2015 was approximately .07 individuals per 100,000.[1][2]

Case Fatality Rate

  • The overall annual case fatality rate for diptheria ranges between 5 and 10%.[3]
    • The annual case fatality rates for patients that are younger than 5 or older than 40 years old tend to be higher, ranging up to 20%.

Age

  • Diphtheria most commonly affects children under the age of 5 years old and without vaccination.[4]
  • Individuals over 50 years old are particularly susceptible to diphtheria, particularly those over 70 years old, due to the higher probability of lacking vaccination.[5][6]

Gender

  • There is evidence that women are more prone than men to diphtheria infection due to lower antitoxin responses to vaccination, requiring more frequent booster administrations.[7]

Race

There is no racial predisposition to diphtheria.

Developing Countries

Diphtheria cases reported to the World Health Organization between 1997 and 2006 (see description for legend).
  • Diphtheria incidence is highest in developing countries due to lack of available vaccination.[8]
  • Developing countries of which Diphtheria is endemic to include Indonesia, Thailand, Laos, and many others in Asia, the South Pacific, Middle East, Haiti, Dominical Republic, South America, and Eastern Europe.[9]
    • A diphtheria resurgence occurred in former Soviet states that comprise present day Eastern Europe, spreading past Europe into Asia and the Middle East.[10]
      • By 1998, there were an estimated 200,000 cases in Eastern Europe, with 5,000 fatal incidences.[11]
    • Outbreaks in Haiti and the Dominican Republic led to a resurgence in the Americas, including a rare fatal case in the United States in 2003 involving a Pennsylvania resident returning from Haiti.[12]



Table 3-01. Countries with endemic diphtheria

REGION COUNTRIES
Africa Algeria, Angola, Egypt, Eritrea, Ethiopia, Guinea, Niger, Nigeria, Sudan, Zambia, and other sub- Saharan countries
America Bolivia, Brazil, Colombia, Dominican Republic, Ecuador, Haiti, and Paraguay
Asia/South Pacific Bangladesh, Bhutan, Burma (Myanmar), Cambodia, China, India, Indonesia, Laos, Malaysia, Mongolia, Nepal, Pakistan, Papua New Guinea, Philippines, Thailand, and Vietnam
Middle East Afghanistan, Iran, Iraq, Saudi Arabia, Syria, Turkey, and Yemen
Europe Albania, Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Russia, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan

Developed Countries

  • Diphtheria is rare in developed, industrialized countries due to longstanding, widespread administration of TDaP vaccine.[11]


References

  1. "WHO World Health Organization: Immunization, Vaccines And Biologicals. Vaccine preventable diseases Vaccines monitoring system 2016 Global Summary Reference Time Series: DIPHTHERIA".
  2. "2015 World Population Data Sheet".
  3. "Diphtheria Infection | Home | CDC".
  4. "WHO | Diphtheria".
  5. Wagner KS, White JM, Crowcroft NS, De Martin S, Mann G, Efstratiou A (2010). "Diphtheria in the United Kingdom, 1986-2008: the increasing role of Corynebacterium ulcerans". Epidemiol. Infect. 138 (11): 1519–30. doi:10.1017/S0950268810001895. PMID 20696088.
  6. Wagner KS, White JM, Andrews NJ, Borrow R, Stanford E, Newton E, Pebody RG (2012). "Immunity to tetanus and diphtheria in the UK in 2009". Vaccine. 30 (49): 7111–7. doi:10.1016/j.vaccine.2012.09.029. PMID 23022148.
  7. Hasselhorn HM, Nübling M, Tiller FW, Hofmann F (1997). "[Diphtheria booster immunization for adults]". Dtsch. Med. Wochenschr. (in German). 122 (10): 281–6. doi:10.1055/s-2008-1047609. PMID 9102270.
  8. "Pinkbook | Diphtheria | Epidemiology of Vaccine Preventable Diseases | CDC".
  9. "Diphtheria - Chapter 3 - 2016 Yellow Book | Travelers' Health | CDC".
  10. Galazka AM, Robertson SE, Oblapenko GP (1995). "Resurgence of diphtheria". Eur. J. Epidemiol. 11 (1): 95–105. PMID 7489783.
  11. 11.0 11.1 "Current Developments in Biotechnology and Bioengineering: Human and Animal ... - Google Books".
  12. "Fatal respiratory diphtheria in a U.S. traveler to Haiti--Pennsylvania, 2003". MMWR Morb. Mortal. Wkly. Rep. 52 (53): 1285–6. 2004. PMID 14712177.


Template:WikiDoc Sources

[[Category: